A study partnered with GenFleet, conducted in China, had its data presented in Barcelona on August 14, 2025, involving Verastem Oncology.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A study partnered with GenFleet, conducted in China, had its data presented in Barcelona on August 14, 2025, involving Verastem Oncology.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barcelona
city in Catalonia, Spain
-
Spain
country in southwestern Europe with territories in Africa
-
China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China
-
Verastem Oncology
Pharmaceutical company in Masachussets, United States
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Business WireVerastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung